Form D · Other Health Care

Protean Biodiagnostics Inc.

Orlando, FL · CIK 0001776193

Offering snapshot reported Dec 7, 2023 · SEC filing

Reported sold
Yet to sell
Offering amount: $6M
Investors reported
0
Form D · investor count
Minimum accepted
$50K
Reported outside-investor minimum
First sale
Yet to occur
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 7, 2023InitialYet to sellNo comparison0SEC filing
May 18, 2021InitialYet to sellNo comparison12SEC filing
May 14, 2021AmendmentYet to sellNo comparison0SEC filing
Jan 4, 2021InitialYet to sellNo comparison0SEC filing
Jun 27, 2019Initial$330,000No comparison4SEC filing

Offering details

Securities
Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$360K
Finders' fees
$0
Form D file number
021-499029
Simple Agreement for Future Equity
If offering is fully subscribed.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Robert N. Cunjak6953909Tangent Capital Partners, LLC · CRD 146999

Source: Form D, filed Dec 7, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Anees Chagpar Director
Ronen Israel Director
Violet Jameson Director
Susan Lee Executive
Anthony Martin Magliocco Director, Executive
Frank Morsani Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
6555 Sanger Road, Suite 232
Orlando, FL, 32827